FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1196.1354.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.1354/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354 |
| Version | 20240525 |
| Status | active |
| Date | 2024-05-25T01:02:23-04:00 |
| Name | CefiximePreparationsForOralAdministration |
| Title | Cefixime preparations for oral administration |
| Realm | us |
| Authority | hl7 |
| Description | cefixime preparations for PO administration of an 800 mg dose |
| Purpose | (Clinical Focus: cefixime preparations for PO administration of an 800 mg dose),(Data Element Scope: MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: human prescribable drugs (TTY SCD or SBD) with ingredient (TTY IN) of RxNorm 25033 'cefixime'),(Exclusion Criteria: No Exclusions) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1196.1354",
"meta": {
"versionId": "8",
"lastUpdated": "2024-05-25T01:02:23.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "CDC DSTDP Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-05-25"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-05-25"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1196.1354"
}
],
"version": "20240525",
"name": "CefiximePreparationsForOralAdministration",
"title": "Cefixime preparations for oral administration",
"status": "active",
"date": "2024-05-25T01:02:23-04:00",
"publisher": "CDC DSTDP Steward",
"description": "cefixime preparations for PO administration of an 800 mg dose",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: cefixime preparations for PO administration of an 800 mg dose),(Data Element Scope: MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: human prescribable drugs (TTY SCD or SBD) with ingredient (TTY IN) of RxNorm 25033 'cefixime'),(Exclusion Criteria: No Exclusions)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1043022",
"display": "cefixime 100 MG Chewable Tablet"
},
{
"code": "1043025",
"display": "cefixime 100 MG Chewable Tablet [Suprax]"
},
{
"code": "1043027",
"display": "cefixime 150 MG Chewable Tablet"
},
{
"code": "1043029",
"display": "cefixime 150 MG Chewable Tablet [Suprax]"
},
{
"code": "1043030",
"display": "cefixime 200 MG Chewable Tablet"
},
{
"code": "1043031",
"display": "cefixime 200 MG Chewable Tablet [Suprax]"
},
{
"code": "105207",
"display": "cefixime 200 MG Oral Tablet [Suprax]"
},
{
"code": "1372999",
"display": "cefixime 400 MG Oral Capsule [Suprax]"
},
{
"code": "1373014",
"display": "cefixime 100 MG/ML Oral Suspension"
},
{
"code": "1373016",
"display": "cefixime 100 MG/ML Oral Suspension [Suprax]"
},
{
"code": "197450",
"display": "cefixime 200 MG Oral Tablet"
},
{
"code": "197451",
"display": "cefixime 400 MG Oral Tablet"
},
{
"code": "213927",
"display": "cefixime 400 MG Oral Tablet [Suprax]"
},
{
"code": "309058",
"display": "cefixime 20 MG/ML Oral Suspension"
},
{
"code": "409823",
"display": "cefixime 400 MG Oral Capsule"
},
{
"code": "410018",
"display": "cefixime 200 MG Oral Capsule"
},
{
"code": "419784",
"display": "cefixime 8 MG/ML Oral Suspension"
},
{
"code": "419849",
"display": "cefixime 40 MG/ML Oral Suspension"
},
{
"code": "581574",
"display": "cefixime 20 MG/ML Oral Suspension [Suprax]"
},
{
"code": "705008",
"display": "cefixime 40 MG/ML Oral Suspension [Suprax]"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:d827ccb2-cd17-4fc7-9cd1-e7ec3e478f38",
"timestamp": "2025-05-23T19:12:52-04:00",
"total": 10,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1043022",
"display": "cefixime 100 MG Chewable Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1043030",
"display": "cefixime 200 MG Chewable Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1372999",
"display": "cefixime 400 MG Oral Capsule [Suprax]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1373014",
"display": "cefixime 100 MG/ML Oral Suspension"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "197450",
"display": "cefixime 200 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "197451",
"display": "cefixime 400 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "309058",
"display": "cefixime 20 MG/ML Oral Suspension"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "409823",
"display": "cefixime 400 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "419849",
"display": "cefixime 40 MG/ML Oral Suspension"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "581574",
"display": "cefixime 20 MG/ML Oral Suspension [Suprax]"
}
]
}
}